Spotify stock falls again as Barclays trims target and investors look to Feb. 10 results
22 January 2026
1 min read

Spotify stock falls again as Barclays trims target and investors look to Feb. 10 results

New York, Jan 21, 2026, 19:26 ET — After-hours

  • Spotify shares slipped 1.8% on Wednesday, lagging behind gains in the wider market
  • Barclays lowered its price target for Spotify to $625 but maintained its Overweight rating
  • Upcoming triggers: the quarterly report on Feb. 10 and a U.S. price hike in February

Spotify Technology S.A. shares dipped 1.8% on Wednesday, ending at $502.19, adding to a rocky start for the music-streaming company in 2026. The stock has fallen roughly 13.5% since the beginning of the year, losing over 6% in the last five sessions alone. 1

This matters now because Spotify’s January results are shaping up as a test of expectations, not merely earnings. Traders have been quick to sell into rallies in high-multiple media stocks, with Spotify standing out as one of the clearest signals.

Barclays dropped its price target on Spotify to $625 from $700 but maintained an Overweight rating, suggesting it still expects the stock to outperform its peers. The bank noted “tactical concerns” about both Disney and Spotify but believes they remain well-positioned to benefit from long-term changes in the media landscape. 2

Spotify lagged behind despite a solid day for U.S. equities. The S&P 500 climbed 1.16%, and the Nasdaq Composite gained 1.18%, but Spotify slid roughly 11.75% over the last month, according to Nasdaq data. 3

Beyond the tape, investors are keeping an eye on Spotify’s push into audiobooks. According to The Verge, the company is trialing a new “Page Match” feature that uses a phone’s camera and optical character recognition to link a physical book page with the corresponding audiobook timestamp. This setup is designed to cut down on manual skipping. 4

Pricing remains a hot topic. Last week, Spotify announced it will hike its monthly Premium subscription by $1 to $12.99 in the US, Estonia, and Latvia starting February. The move aims to boost funding for platform upgrades and creator support. 5

Price hikes cut both ways. If churn rises—customers cancelling, downgrading, or delaying payments—the market will notice fast, especially given Apple, Amazon, and YouTube offer alternatives that don’t depend on Spotify’s ad-and-audio setup.

Thursday’s session will test if the sell-off continues or if the next analyst note challenges the prevailing valuation concerns after yesterday’s close-to-close drop.

Spotify’s fourth-quarter earnings drop Tuesday, Feb. 10, ahead of the open, with a Q&A set for 8 a.m. ET, per a Business Wire release.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
AbbVie stock rises after-hours as Bernstein sticks with $225 target ahead of Feb. 4 earnings
Previous Story

AbbVie stock rises after-hours as Bernstein sticks with $225 target ahead of Feb. 4 earnings

Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade
Next Story

Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade

Go toTop